Sunshine Biopharma Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Sunshine Biopharma Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00.
- Sunshine Biopharma Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- Sunshine Biopharma Inc. payments for repurchase of common stock for the quarter ending 2025-06-30 was $0.00.
- Sunshine Biopharma Inc. payments for repurchase of common stock for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. payments for repurchase of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Sunshine Biopharma Inc. payments for repurchase of common stock for fiscal 2024 was $3.14M, a 480.19% increase from fiscal 2023.
- Sunshine Biopharma Inc. payments for repurchase of common stock for fiscal 2023 was $541.14K.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $0.00 10-K · filed 2026-04-03 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-04-03 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-04-03 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-04-03 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $3.14M 10-K · filed 2026-04-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.14M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | |
| 2024-03-31 | $3.14M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $541.14K 10-K · filed 2025-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |